| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.089 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.078 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |